Posts by Sandra Ansanay-Alex
Geneva Unveils Master Plan To Become An Innovation Hub
The State of Geneva has unveiled an ambitious master plan aimed at transforming the canton into a global innovation hub. In addition to the CHF 10 million already invested annually in the sector, an extra CHF 11 million will be injected over the next three years, until 2027. Unveiled at Campus Biotech by State Councilor…
Read MoreCSEM receives a CHF 3 Million Funding from Canton of Neuchâtel
The Canton of Neuchâtel has announced a strategic initiative to support the semiconductor industry, recognizing its pivotal role in technological innovation and economic growth. As part of this plan, the Swiss Center for Electronics and Microtechnology (CSEM) will receive CHF 3 million in innovation funding between 2024 and 2028, enabling it to modernize its equipment…
Read MorePhilippe Renevey Wins CSEM Inventor Award 2025
More than two decades after CSEM pioneered wrist-based pulse monitoring, engineer Philippe Renevey is being honored with the CSEM Inventor Award 2025 for his revolutionary PulseSpeed patent. This breakthrough innovation enables high-precision heart rate measurement, opening new possibilities for wearable health technology. The Science Behind PulseSpeed Whether jogging, climbing stairs, or simply walking, smartwatches…
Read MoreDebiotech : Pioneering Medical Device Innovation since 35 Years
2025 marks a significant milestone for Debiotech as it celebrates 35 years of innovation in medical device development. The Vaud-based company also recently evolved into a contract engineering company. In 2025, Debiotech proudly celebrates 35 years of pioneering innovations in the medical device sector. With an outstanding legacy of excellence in designing advanced drug…
Read MoreAB2 Bio & Nippon Shinyaku Partner on U.S. License for Tadekinig Alfa
AB2 Bio and Nippon Shinyaku Sign U.S. Licensing Agreement for Tadekinig Alfa to Treat Ultra-Rare Autoimmune Disease AB2 Bio Ltd., a Vaud-based biotech company specializing in therapies for severe hyperinflammatory diseases, has entered into a strategic agreement with Nippon Shinyaku, a leading Japanese pharmaceutical company, for the commercialization of its breakthrough treatment Tadekinig alfa…
Read MoreSurvey: Ready for the Sustainable Transition?
Our partner, CleantechAlps, in collaboration with regional economic players, wants to better understand your challenges and needs to develop tailored solutions for sustainable transition. We thank you for answering the survey. With the arrival of ESG reporting, these new regulations will soon impact the entire economic landscape. By participating in this survey, you have…
Read MoreGeneva to Launch AI Hub for Healthcare and Neuromodulation
The University Hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva, and the Wyss Center for Bio and Neuro Engineering have signed a three-party agreement to establish an AI reference hub focused on healthcare and neuromodulation. Set to launch in late 2025, this initiative aims to enhance the…
Read MoreOculis Announce a $100 Million Capital Increase
Swiss-Icelandic ophthalmic laboratory Oculis announced a $100 million capital increase on Friday. The financial operation was carried out through an oversubscribed offering of 5 million shares at $20 each. Born in 2017 in Iceland, the company then expanded to the EPFL Innovation Park before setting up its headquarters in Zug. It has offices…
Read MoreWyss Center licenses Epios® to BrainScape Medical
The Wyss Center for Bio and Neuro Engineering announced a strategic partnership with BrainScape Medical, a newly formed company specializing in long-term brain monitoring and neurostimulation. This collaboration marks a major step forward in translating innovative neurotechnologies into real clinical solutions. The Wyss Center in Geneva has granted BrainScape Medical an exclusive license for…
Read MoreLaunch of the Deep Tech Nation Information Platform
The Deep Tech Nation Switzerland Foundation (DTN) and the Startupticker Foundation have launched the Deep Tech Nation Information Platform to help venture capitalists (VCs) and institutional investors navigate Switzerland’s deep tech ecosystem. The platform enhances access to information, promotes investment in Swiss deep tech start-ups, and aims to strengthen Switzerland’s position as a…
Read More